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To characterize the active domain of the simian immunodeficiency virus (SIV) surface unit (SU) enterotoxin, peptides corresponding to
the V3 loop of SIVmac239 (SIVmac) and SIVsmmPBj41 (SIVpbj) were synthesized and examined for enterotoxic activity, a-helical
structure, and interaction(s) with model membranes. SIVmac and SIVpbj induced a dose-dependent diarrhea in 6–8-day-old mouse pups
similar to full-length SU. The peptides mobilized [Ca2+]i in HT-29 cells with distinct oscillations and elevated inositol triphosphate levels.
Circular dichroism analyses showed the peptides were predominantly random coil in buffer, but increased in a-helical content when
placed in a hydrophobic environment or with cholesterol-containing membrane vesicles that are rich in anionic phospholipids. None of the
peptides underwent significant secondary structural changes in the presence of neutral vesicles indicating ionic interactions were
important. These data show that the SIV SU enterotoxic domain localizes in part to the V3 loop region and interacts with anionic
membrane domains on the host cell surface.
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Alterations in gastrointestinal (GI) function, including
chronic diarrhea, malabsorption, and significant weight
loss, are devastating characteristics of human immunode-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Station, TX 77845.ficiency virus (HIV) or simian immunodeficiency virus
(SIV) infection and account for the frequently observed
wasting syndrome of acquired immunodeficiency syn-
drome (AIDS) or simian AIDS (SAIDS) (Ehrenpreis et
al., 1992). There are numerous HIV or SIV cases in
which secondary enteric pathogens cannot be identified
as the causative agent of the diarrhea and wasting (Heise
et al., 1991, 1993; Lambl et al., 1996; Ullrich et al.,
1989); hence, it is plausible that the virus, viral replica-
tion, or a viral protein is responsible for the (GI)
dysfunction. In an earlier report, we showed purified
SIVmac surface unit (SU) induces a dose-dependent
diarrheal response in 6–8-day-old Balb/C mouse pups,
promotes fluid accumulation in adult mouse intestinal
loops in the absence of histological alterations, promotes
chloride (Cl) secretory currents across unstripped mouse
intestinal mucosa as measured in Ussing chambers, and
increases inositol triphosphate (IP3) and intracellular cal-
cium ([Ca2+]i) levels in HT-29 colonic cells. These data
fulfill the criteria of an enterotoxin making SIV SU the
second viral enterotoxin to be described (Swaggerty et al.,
2000).
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envelope glycoproteins of HIV or SIV (Hunter and Swan-
strom, 1990; Medina et al., 1999). SU determines the host
range and cell tropism of the virus by functioning as the
viral receptor. The envelope glycoproteins, SU and trans-
membrane (TM), also contribute to the cytopathicity of the
virus by inducing cell lysis or syncytium formation of
target cells (Hunter and Swanstrom, 1990). SU is weakly
bound to TM and can freely dissociate leading to immune-
mediated killing of uninfected target cells (Hunter and
Swanstrom, 1990) or may contribute to GI dysfunction
(Swaggerty et al., 2000).
The pathogenesis of SIV or HIV infections is very
complex and not fully understood. The auxiliary nef gene
overlaps env and contributes to disease in rhesus macaques
(Macaca mulatta) (Alexander et al., 1999; Du et al., 1995;
Kirchhoff et al., 1999; Lou and Peterlin, 1997; Sawai et al.,
1996). SIVmac239 is a virus derived from an infectious
molecular clone and causes a typical lentivirus infection
with slow progression to disease that often results in SAIDS
in infected macaques (Alexander et al., 1999; Kaur et al.,
1998; Kestler et al., 1990; Naidu et al., 1988). However,
SIVmac239 can undergo mutations that result in a highly
pathogenic virus that causes severe GI dysfunction and
disease. In many cases, the mutations occur in codon 17
of nef that causes a predicted amino acid change at residue
17 from Arg to Tyr, a pattern typically found in the acutely
pathogenic SIVsmmPBj14 strain (Du et al., 1995; Kirchhoff
et al., 1999; Lou and Peterlin, 1997).
SIVsmmPBj14 (SIVpbj14) is an atypical, pathogenic
clone of SIV that causes an acute clinical syndrome
characterized by depression, anorexia, fever, profuse diar-Fig. 1. SIVmac and SIVpbj induced a dose-dependent diarrhea in 6–8-day-old B
determined to be free of endotoxin. The x-axis shows the dose of peptide admin
diarrhea. Control pups were inoculated with purified SIVcon (C terminus of SU) o
0.42 mM, respectively, based on the calculations of Reed and Muench (1938).rhea, dehydration, wasting, and death within 6–10 days
post infection (Fultz et al., 1989; Lewis et al., 1992;
Swanstrom and Wills, 1997). SIVpbj14 infects and causes
disease in different strains of monkeys including the pig-
tailed cynomolgus (Macaca fascicularis), sooty manga-
beys (Cercocebus atys), and to a more variable degree,
rhesus macaques (Fultz, 1994; Fultz et al., 1989; Lewis et
al., 1992). The other SIV strains are generally species-
specific in that symptoms rarely occur in multiple species.
The extensive lymphoid hyperplasia of T cells, particular-
ly in the gut-associated lymphoid tissues (GALT), is one
of the most important pathological features associated
with SIVpbj14 infections. Viral threshold in the GALT
directs the disease course in infected pig-tailed macaques
wherein a single log dilution difference determines if an
animal succumbs to disease and dies (Fultz, 1994; Fultz et
al., 1989). Because SIVpbj14 induces a high titer viremia,
an extensive number of immune cells are activated,
proliferate, and produce cytokines. The increased produc-
tion of cytokines, in particular TNFa and IL-6, results in
an acute inflammatory disease in the GI tract, hemorrhag-
ing or bloody diarrhea, and intestinal tissue destruction
(Farthing, 2000; Fultz and Zack, 1994; Fultz et al., 1989;
Lewis et al., 1992). In addition to the GI dysfunction,
infected pig-tailed macaques often deteriorate rapidly after
the onset of anorexia or depression yet before the onset of
diarrhea. The exact roles of inflammation and disease
progression remain unclear. Virus has been isolated from
lymphoid tissue such as the tonsils of SIVpbj14-infected
monkeys in the complete absence of mucosal inflamma-
tion (Swanstrom and Wills, 1997). A high titer viremia
during disease progression in SIVpbj14-infected monkeysalb/C mice. Each dose was administered in 50 Al of sterile PBS and was
istered (mM) and the y-axis shows the percentage of pups that developed
r PBS only. The calculated DD50 of SIVmac and SIVpbj was 0.15 mM and
C.L. Swaggerty et al. / Virology 320 (2004) 243–257 245would likely yield an excess of viral protein, such as SU,
which could complicate the GI alterations by functioning
as a viral enterotoxin, similar to SIVmac239 SU, in intact
enterocytes.
Several studies show that the third variable domain (V3
loop) of SU is associated with HIV or SIV pathogenesis
(Hunter and Swanstrom, 1990; Nelson et al., 2000; Pro-
chiantz, 2000; Sakaida et al., 1998). HIV-1 SU induces
[Ca2+]i mobilization from caffeine-sensitive stores in HT-
29 colonic cells that are ablated by V3- or galactosylcer-
amide (GalCer) receptor-specific antibodies (Dayanithi et
al., 1995). Based on these data, the authors speculate that
the V3 region is enteropathic and contributes to the
wasting seen in HIV-infected patients by promoting fluid
secretion in the GI tract (Dayanithi et al., 1995). In the
current study, we selected analogous regions of SU
corresponding to the putative enterotoxic HIV V3 loop
sequence from two diverse SIV strains, SIVmac239 and
SIVsmmPBj41, and determined if these SIV peptides were
enterotoxic. Specifically, peptides were tested for diarrhea-
genic activity in a mouse model and for induction of IP3
and [Ca2+]i levels in a human intestinal cell line. To
evaluate structure and membrane interactions, we per-
formed circular dichroism (CD) analyses and characterized
peptide–membrane interactions.Fig. 2. Hematoxylin and eosin staining of the mucosa from the mouse
intestinal loops. (A) SIVmac-treated loop with a normal number of
lymphocytes (white, closed arrow) and goblet cells (white, open arrow).
The columnar epithelium and microvilli brush-border (black, closed arrow)
are unaltered, indicating there are no histological alterations induced by the
addition of SIVmac to the intestinal loop. This tissue also has a capillary
with red blood cells (white *) that is visible. (B) SIVpbj-treated loop with
an equal number of lymphocytes (white, closed arrow) and goblet cells
(white, open arrow). The columnar epithelium and the microvilli brush-
border remained intact (black, closed arrow). (C) SIVcon-treated intestinal
loop with comparable numbers of lymphocytes (white, closed arrow) and
goblet cells (white, open arrow). The columnar epithelium and the
microvilli brush-border remained intact (black, closed arrow). (D) PBS-
treated loop with a normal population of lymphocytes (white, closed arrow)
and goblet cells (white, open arrow). The columnar epithelium and the
microvilli brush-border are intact (black, closed arrow).Results
SIV SU synthetic peptides induced a dose-dependent
diarrhea in a mouse model
Each peptide or PBS was independently inoculated IP
into 6–8-day-old Balb/C mouse pups and diarrhea was
monitored for 24 h. The diarrhea responses to the peptides
were specific, as administration of purified SIVcon or the
same volume of PBS had little or no effect. Administration
of 2 mM SIVcon induced minimal diarrhea in 1/29 (3.4%)
of the pups and none of the animals (0/20) administered an
equal volume of PBS developed diarrhea (Fig. 1). The
incidence of diarrhea ranged from 0% to 80% following
administration of 0.5 AM to 10 mM of purified SIVmac or
SIVpbj showing a dose response. Based on the calcula-
tions of Reed and Muench (1938), the diarrhea dose 50
(DD50) for SIVmac and SIVpbj was 0.15 and 0.42 mM,
respectively. These data indicate a lower dose of SIVmac
is required for diarrheagenic activity compared to SIVpbj
in the mouse model.
For both peptides, the onset of diarrhea was typically
within 2 h post administration and continued for up to 8 h,
occasionally for up to 24 h. When animals administered
with either SIVmac or SIVpbj had severe diarrhea (3 to 4+),
they often exhibited lower body temperatures or were
lethargic compared to those animals administered the con-
trol inoculums. These symptoms are similar to those ob-
served with IP administration of full-length SIV SU(Swaggerty et al., 2000), HIV-1 SU (Ball and Estes, unpub-
lished data), and NSP4114–135 (Ball et al., 1996). Also like
the NSP4 enterotoxin, a significantly higher dose of peptide
was required when compared to full-length protein to yield
equivalent effects, that is, the DD50 of SIV SU is 0.13 nmols
(Swaggerty et al., 2000).
Histological analysis of SIV SU peptide-treated intestinal
loops
Histological evaluations of the tissue and mucosa of the
SIVmac-, SIVpbj-, and SIVcon-treated intestinal loops
appeared identical (Figs. 2A–C) to the PBS-treated loops
(Fig. 2D). Minimal accumulation of neutrophils was ob-
served within and around vessels of the mesentery in both
treated and nontreated intestinal tissues. The accumulation
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manipulation of tying off the loops and subsequent han-
dling during the surgical procedures. No significant lesions
or other alterations were observed within the mucosa of
any specimens examined from the treatment or control
groups. In all tissues examined, the columnar epithelium
and microvilli brush border remained intact and there were
normal populations of lymphocytes and goblet cells. These
data indicate that the secretory response induced by the
peptides was not due to cell damage.
SIV SU peptides induced intracellular calcium mobilization
in cultured HT-29 cells
[Ca2+]i mobilization by SIVmac, SIVpbj, or SIVcon
was monitored in Fluo-4-loaded HT-29 cells. Addition of
300 AM of each peptide (n = 4) increased [Ca2+]i levels
above the basal levels observed in unstimulated cells;
however, there were notable differences in the intensityFig. 3. SIV SU peptides mobilized [Ca2+]i in Fluo-4-loaded HT-29 cells. The x
measured on the gray scale. Representative cell responses are shown from four diff
(n = 4). (C) SIVcon-treated cells (n = 4). (D) Neurotensin-treated cells (positiveof the response and the observed patterns (Fig. 3). For
comparative purposes, an intensity level of 40 was select-
ed. Fig. 3A shows representative cells from four different
experiments in which cells were treated with SIVmac.
Seven out of 21 cells (33%) reached fluorescence intensity
levels of 40 or greater while 18/22 (82%) of the cells
treated with SIVpbj (Fig. 3B) reached levels of 40 or
greater. Hence, the SIVpbj peptide was more active in
[Ca2+]i mobilization when compared to SIVmac despite a
higher DD50, perhaps due to the use of human cells.
Although SIVcon-treated cells reached intensity levels
comparable to the SIVmac-treated cells (6/20 or 30%,
Fig. 3C), there was a significant difference in the pattern
of [Ca2+]i mobilization indicating a different response. In
SIVmac-treated cells that reached intensity levels of 40 or
greater, 5/7 (71%) cells had an oscillating calcium re-
sponse at some point during the experiment; however, the
SIVcon-treated cells gradually plateau with no oscillations.
Likewise, there was a marked difference in the [Ca2+]i-axis is the time (seconds) and the y-axis is the fluorescence intensity as
erent experiments. (A) SIVmac-treated cells (n = 4). (B) SIVpbj-treated cells
control, n = 2).
Fig. 4. SIVmac and SIVcon localized to the plasma membrane and in the
cytoplasm of HT-29 colonic cells as demonstrated by IFA. (A) HT-29 cells
treated with SIVmac, mouse-anti-SIVmac, and FITC-conjugated goat-anti-
mouse IgG showing staining on the plasma membrane and (B) in the
cytoplasm. (C) HT-29 cells treated with SIVcon, rabbit-anti-SIVcon, and
FITC-conjugated goat-anti-rabbit IgG. White closed arrow denotes
cytoplasmic staining and the white open arrow is directed at the plasma
membrane staining of a neighboring cell.
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Of the 18 cells that reached intensity levels of 40 or
greater, 16/18 (89%) responded with oscillations or multi-
ple oscillations within the same cell. Cells treated with
neurotensin responded as previously reported (Swaggerty
et al., 2000) and served as positive control (Fig. 3D).
Specificity of the calcium response
Peptide-specific antisera greatly reduced the [Ca2+]i
mobilization induced by SIVmac and SIVpbj, indicating
the response is specific. One out of seven cells (14.3%)
barely reached fluorescence intensity levels of 40 when
treated with SIVmac blocked with 1:10 dilutions of SIV-
mac-specific antiserum. When SIVmac was treated with a
1:100 dilution of anti-SIVmac, none of the cells reached
intensity levels of 40 or greater. Similarly, only 1/7
(14.3%) or 0/6 cells reached intensity levels of 40 when
treated with SIVpbj blocked with 1:10 or 1:100 dilutions
of anti-SIVmac, respectively. Treatment with SIVmac
antiserum also eliminated the oscillating calcium responses
induced by SIVmac and SIVpbj. The effects of anti-
SIVcon antiserum on SIVcon-induced calcium response
were different. When SIVcon was blocked with a 1:10
dilution of anti-SIVcon, 6/7 (85.7%) of the cells reached
intensity levels of 40 with a transient calcium response as
opposed to the sustained response induced by untreated
SIVcon. Only 1/7 (14.3%) cells reached an intensity level
of 40 when SIVcon was blocked with a 1:100 dilution of
SIVcon antiserum. Both SIV peptide-specific antisera
failed to alter the effects of neurotensin (data not shown),
indicating the antibody block was specific.
SIV peptides localized to the plasma membrane and
cytoplasm of HT-29 colonic cells
Based on the elevated and sustained calcium responses,
we investigated the cellular location of the peptides in
HT-29 cells using an immunofluorescence assay (IFA).
SIVmac was present on the outside of the plasma
membrane (Fig. 4A) as well as in the cytoplasm (Fig.
4B) of the cell. Although HT-29 cells tend to clump, care
was taken to indicate single cells (arrows, Figs. 4A–C).
SIVcon was also found on the plasma membrane (white
open arrow) and in the cytoplasm (white closed arrow) of
the cell (Fig. 4C). Cells treated with peptide alone did not
fluoresce, nor did cells fluoresce when treated with
peptide reacted with species-specific preimmune serum
or secondary antibody alone. To ensure that the dye
loading procedure did not affect the location of the
peptide, an IFA also was conducted with cells that
underwent mock dye loading before treatment with SIV-
con which showed no difference in the observed staining
pattern. Although SIVpbj-specific antibody was not avail-
able, SIVpbj would likely cross the membrane, as its
molecular weight and amphipathic properties are similarto SIVmac and SIVcon. Thus, the SU peptides likely act
by a different mechanism than the full-length protein to
alter calcium homeostasis in the cells when exogenously
added to human intestinal cells.
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A competitive radioreceptor assay was utilized to mea-
sure IP3 levels in HT-29 cells treated with SIVmac, SIVpbj,
SIVcon, neurotensin, or PBS. SIVmac (n = 4) and SIVpbj
(n = 3) (300 AM) increased IP3 levels 265% and 259%
above basal levels, respectively (Fig. 5). Cells treated with
300 AM SIVcon increased levels 153% above background
levels observed in buffer-treated cells (n = 3). Although the
SIVcon peptide increased IP3 levels, the SIVmac and
SIVpbj bioactive peptides increased IP3 levels significantly
above SIVcon-treated cells (P < 0.05). Cells treated with
0.01 AM neurotensin (n = 4) responded as previously
reported (Swaggerty et al., 2000) and served as positive
control (not shown). The significant differences in dose of
the SIV peptides compared to neurotensin to induce both the
IP3 and calcium responses are likely receptor-related or
could be due to (1) the peptide not corresponding to the
complete binding domain, (2) reduced innate IP3 stimula-
tion of the SIV peptides, or (3) failure of the SIV peptides to
fold in a native conformation.
Secondary structure of the SIV SU peptides promoted in a
hydrophobic environment
CD spectra of all three peptides in buffer showed mostly
random coil characteristics with a strong negative absorp-
tion at approximately 200 nm and very weak negative
absorption at 222 nm (Figs. 6–8 panel A, dark circles).
These data are not surprising as peptide structure is fre-
quently disordered in an aqueous environment (Lark et al.,
1989). Fractions of a-helix calculated for SIVmac, SIVpbj,
C.L. Swaggerty et al. / V248Fig. 5. SIV SU peptides induced an increase in IP3 levels in HT-29 cells. The x-ax
the percent increase in IP3 levels above background levels in untreated cells.
respectively. SIVcon (300 AM) increased levels 153% above the basal levels.and SIVcon were 0.14, 0.17, and 0.15, respectively (Table
1). Thus, SIVpbj with 17% a-helix showed the most innate
helical structure.
To evaluate the peptide structure in a more hydropho-
bic environment, 50% trifluoroethanol (TFE) was utilized.
In this hydrophobic solvent, the CD spectra of all three
peptides showed typical a-helix characteristics, that is,
negative absorption at 222 and 208 nm, and positive
absorption at 190 nm (Figs. 6–8 panel A, open circles).
Only those peptides with a strong structural propensity
demonstrate an ordered structure when placed in an
optimal environment (Shoemaker et al., 1985), indicating
these SU peptides have a strong a-helical propensity. In
50% TFE the a-helical contents of SIVmac, SIVpbj, and
SIVcon were 0.28, 0.32, and 0.31, respectively (Table 1).
These data show at least a 2-fold increase in a-helical
content in the hydrophobic environment when compared
to that in buffer, suggesting a hydrophobic environment,
such as membranes, may organize or promote the a-
helical structure of the peptides.
SIV SU peptides interact with model membranes of distinct
composition and size
Because a hydrophobic environment promoted the
SIV peptide helical structure, the peptides were analyzed
in the presence of small or large unilamellar vesicles
(SUV and LUV, respectively) of different composition.
The overall charge, lipid content, and size of the vesicles
were altered to directly test if alterations in membrane
lipid composition or curvature affected peptide–mem-
brane interactions.is is the treatment administered (all were 45 s with n = 3 or 4). The y-axis is
The 300 AM SIVmac and SIVpbj increased IP3 levels 265% and 259%,
Fig. 6. (Panel A) CD spectra of SIVcon in buffer (dark circles) or 50% TFE (open circles). (Panel B) CD spectra of SIVcon in the presence of
SUV. (Panel C) CD spectra of SIVcon in the presence of LUV. In panels B and C, the lipid compositions of the vesicles were as follows: dark
circles, POPC/Cholesterol = 65:35; open circles, POPC/Cholesterol/DOPS = 55:35:10; dark triangles, POPC/Cholesterol/DOPS = 35:35:30; open
triangles, POPC/Cholesterol/DOPS = 40:50:10. In all the experiments, peptide concentrations were 15 AM, and lipid concentrations of the vesicles
were 1 mM.
C.L. Swaggerty et al. / Virology 320 (2004) 243–257 249Effect of charge
In the presence of SUV composed of neutral lipids
(1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine [POPC
or phosphatidylcholine, PC]/cholesterol molar ratio of
65:35), none of the peptides showed significant changes
in CD spectra or calculated a-helical fraction compared to
the CD spectra observed in buffer (Figs. 6–8 panel B,
dark circles, and Table 1). Because the peptides have a
net positive charge, the concentration of negatively
charged lipid (1,2-dioleoyl-sn-glycero-3-[phospho-L-ser-
ine] [DOPS or phosphatidylserine, PS]) was increased to
10% to evaluate the role of ionic interactions. In the
presence of SUV (PC/cholesterol/PS molar ratio of55:35:10), the SIVpbj and SIVcon peptides showed
slightly more negative absorption at 222 nm compared
to those in buffer or those in the presence of neutral SUV
(Figs. 6–8 panel B, open circles). The a-helical fraction
of SIVpbj increased by 9% and SIVcon increased by 18%
(Table 1). The changes observed for SIVmac were more
profound (Fig. 7, panel B, open circles) as the a-helical
fraction increased by 24% when compared to the a-
helical content in buffer. When PS was increased 30%
in the SUVs, the a-helical fractions further increased to
0.31 for SIVmac, 0.24 for SIVpbj, and 0.22 for SIVcon, a
76%, 24%, and 52% increase compared to buffer alone,
respectively. A high radius of curvature in the absence of
Fig. 7. (Panel A) CD spectra of SIVmac in buffer (dark circles) and 50% TFE (open circles). (Panel B) CD spectra of SIVmac in the presence of
SUV. (Panel C) CD spectra of SIVmac in the presence of LUV. In panels B and C, the lipid compositions of the vesicles were as follows: dark
circles, POPC/Cholesteol = 65:35; open circles, POPC/Cholesterol/DOPS = 55:35:10; dark triangles, POPC/Cholesterol/DOPS = 35:35:30; open
triangles, POPC/Cholesterol/DOPS = 40:50:10. In all the experiments, peptide concentrations were 15 AM, and lipid concentrations of the vesicles
were 1 mM.
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SIV SU peptides. These data indicate the peptides pref-
erentially interact with negatively charged membranes in
the presence of a high radius of curvature similar to
NSP4 peptides (Huang et al., 2001).
Effect of cholesterol concentration
To determine the effect(s) of altering the cholesterol
content of the SUV on the helical content of the SIV
peptides, cholesterol was increased from 35% to 50%
(PC/cholesterol/PS molar ratio of 55:35:10 changed to
40:50:10). This alteration yielded no significant
changes in any of the CD spectra (Figs. 6–8 panelB open triangles vs. open circles) or in the calculated
a-helical fraction, suggesting the increased cholesterol
had no effect on the peptide–membrane interactions
(Table 1).
In the presence of LUV (PC/cholesterol molar ratio
of 65:35 or PC/cholesterol/PS molar ratio of 55:35:10,
or 40:50:10), the CD spectra and calculated a-helical
fractions of the peptides remained essentially the same
(Table 1, Figs. 6–8 panel C, dark circles, open circles,
and open triangles) when compared to peptides in
buffer. However, all three peptides did undergo signif-
icant changes in CD spectra when the LUV PS content
was increased to 30% (Figs. 6–8 panel C, dark
Fig. 8. (Panel A) CD spectra of SIVpbj in buffer (dark circles) and 50% TFE (open circles). (Panel B) CD spectra of SIVpbj in the presence of SUV. (Panel C)
CD spectra of SIVpbj in the presence of LUV. In panels B and C, the lipid compositions of the vesicles were as follows: dark circles, POPC/Cholesteol = 65:35;
open circles, POPC/Cholesterol/DOPS = 55:35:10; dark triangles, POPC/Cholesterol/DOPS = 35:35:30; open triangles, POPC/Cholesterol/DOPS = 40:50:10.
In all the experiments, peptide concentrations were 15 AM, and lipid concentrations of the vesicles were 1 mM.
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The calculated a-helical fraction increased to 0.21 for
SIVmac (19% increase), 0.17 for SIVpbj (14% in-
crease), and 0.16 for SIVcon (13% increase) (Table
1). As was seen with the SUVs, SIVmac underwent
slightly more secondary structural changes than SIVpbj
or SIVcon. To determine if increasing the cholesterol
content in the LUV had an effect on peptide–membrane
interactions, a molar ratio of 55:35:10 was compared to
40:50:10. Similar to the SUV data, altering the choles-
terol content of the LUV did not significantly affect
peptide–membrane interactions (Figs. 6–8 panel B vs.
panel C, and Table 1).In summary, all three peptides adopted a mostly random
coil structure in buffer and formed 28–32% a-helical
structure in 50% TFE. None of the peptides underwent
significant secondary structural changes in the presence of
neutral vesicles (SUV or LUV), whereas the peptides
showed significant (P < 0.01) increases in a-helical content
in the presence of SUV composed of 10% and 30% PS or
LUV with 30% PS. Overall, increasing vesicle PS content
promoted peptide interactions, whereas increasing the cho-
lesterol content had no effect. These data indicate the
peptides are more organized in the presence of anionic
phospholipids. The peptides underwent more secondary
structural changes when reacted with the SUVs than with
Table 1
Calculated a-helical fraction of peptides
Fraction of a-helix (Mean F SE, n = 4)
SIVcon SIVmac SIVpbj
Buffer 0.141 F 0.003 0.174 F 0.002 0.152 F 0.001
50% TFE **0.279 F 0.003 **0.317 F 0.003 **0.306 F 0.001
SUV 65:35:0a 0.147 F 0.002 0.173 F 0.004 0.151 F 0.0004
55:35:10a **0.167 F 0.002 **0.215 F 0.001 **0.165 F 0.001
35:35:30a **0.215 F 0.001 **0.307 F 0.004 **0.239 F 0.002
40:50:10a **0.156 F 0.001 **0.219 F 0.002 **0.169 F 0.003
LUV 65:35:0a 0.145 F 0.004 0.167 F 0.005 0.155 F 0.001
55:35:10a 0.143 F 0.005 0.162 F 0.008 0.152 F 0.002
35:35:30a **0.160 F 0.0001 **0.207 F 0.001 **0.174 F 0.001
40:50:10a 0.151 F 0.001 0.182 F 0.0002 0.158 F 0.0004
a Lipid composition of the vesicles, POPC/Cholesterol/DOPS.
**Significantly different from those of peptide in buffer, P < 0.01.
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preference for membranes with a high radius of curvature.Discussion
The use of synthetic peptides to dissect mechanisms of
viral pathogenesis is well established. Peptide chemistry
was utilized to dissect the functionally active enterotoxic
domain of the first described viral enterotoxin, rotavirus
NSP4 (Ball et al., 1996). NSP4(114–135), a 22 amino acid
residue peptide, maintains the enterotoxic properties asso-
ciated with the full-length NSP4 protein, while other am-
phipathic peptides or single amino acid mutants of
NSP4(114–135) do not induce disease (Ball et al., 1996).
Additionally, the use of synthetic peptides has aided in the
understanding of lentivirus pathogenesis, particularly in
regard to HIV-1 and -2 neutralizing epitopes (Kliger et al.,
2001; Misumi et al., 2003; Sharon et al., 2002) and
coreceptor usage (Barbouche et al., 2000; Cormier et al.,
2000; Dettin et al., 2002; Prochiantz, 2000; Sakaida et al.,
1998). Peptides corresponding to the V3 loop of a T-tropic
HIV-1 strain show V3 interacts with its coreceptor indepen-
dent of the V1 or V2 components of SU or cellular CD4
(Sakaida et al., 1998).
The aim of this study was to localize and further
characterize the enterotoxic region(s) of two distinct SIV
strains, SIVmac239 and SIVsmmPBj14, and to determine
if there is a common enteropathic region within the SIV
SU glycoprotein. Because the original work was per-
formed with an SU recombinant protein generated from
the SIVmac239 strain, it was important to examine the
enterotoxic activity of SU peptides from the SIVmac239
sequence (Swaggerty et al., 2000). The SIVsmmPBj14
SU sequence was selected because of reports of acute GI
dysfunction, disease, and death in monkeys within 6–10
days post infection (Fultz et al., 1989; Lewis et al.,
1992). Although SIVsmmPBj14 is known to damage
the intestinal architecture resulting in malabsorption, it
remains unclear if SIVsmmPBj14 SU also contains enter-
otoxic activity that could contribute to the GI disease. Inthis study, (1) both SIVmac and SIVpbj peptides induced
a dose-dependent diarrheal response in a mouse pup
model; (2) neither peptide altered the histology within
intestinal loops; (3) both peptides mobilized [Ca2+]i and
(4) increased IP3 levels in cultured HT-29 cells; (5) both
peptides demonstrated a dominant random coil secondary
structure that increased in a-helical content in a hydro-
phobic environment; and (6) both peptides preferentially
interacted with cholesterol-containing model membranes
rich in negatively charged lipids, and with high mem-
brane curvature.
Both SIVmac and SIVpbj induced diarrhea in our mouse
model; however, SIVmac was 2.8-fold more active than
SIVpbj (DD50 of 0.15 and 0.42 mM, respectively). It is
possible that the selected sequence for SIVpbj peptide
synthesis was not ideal for enterotoxic activity or the
neonatal mouse intestines may lack the necessary recep-
tor(s) for optimal enterotoxic activity. Alternatively, enter-
otoxic activity may not significantly contribute to SIVpbj14-
induced diarrheal disease. Data obtained from the negative
control peptide, SIVcon, indicate that the C-terminus does
not contribute to diarrhea induction and is likely not part of
the active enterotoxic domain. However, the C-terminal
region of SU may be important in the overall enterotoxic
activity by contributing to the structure of the protein and
interacting with signaling molecules as supported by this
study wherein both IP3 and [Ca2+]i levels are increased by
SIVcon-treated HT-29 cells.
The presence of a viral enterotoxin in SIV or HIV
offers one explanation for the devastating GI dysfunction
or wasting of AIDS or SAIDS (Ehrenpreis et al., 1992;
Heise et al., 1993) when a known causative agent cannot
be identified. This study does not discount those instances
in which the GI disorders are associated with an identi-
fiable enteric pathogen or intestinal disruption, such as
that seen following SIVsmmPBj14 infection (Farthing,
2000; Fultz and Zack, 1994; Fultz et al., 1989; Lewis
et al., 1992). However, the data do support the presence
of an SIV SU enterotoxic domain that may contribute to
the wasting syndrome of HIV or SIV infections. No
histological alterations were noted in any of the treated
loops, further indicating an enterotoxic pathway rather
than malabsorption. Both bioactive peptides increased IP3
levels 1.7-fold more than SIVcon, in agreement with the
HIV data showing the V3 loop region contains enter-
otoxic activity (Dayanithi et al., 1995).
The calcium responses elicited by the SIV peptides
were distinct from the full-length SU response (Swaggerty
et al., 2000) in that it was sustained rather than transient
and had clear oscillations. The SIV peptide responses were
similar to that observed when HIV-1 Tat was added to
neurons with [Ca2+]i levels rarely returning to baseline
after peptide addition and undergoing fluxes representative
of calcium oscillations or waves (Haughey et al., 1999).
The observed calcium response was typically initiated
within seconds after the addition of the SIV peptides.
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times of a few seconds are generally IP3-mediated (Roo-
ney and Thomas, 1993; Sanderson et al., 1990, 1994). The
elevated IP3 levels in the SIV peptide-treated intestinal
cells further support an IP3-mediated calcium response.
However, there are alternative explanations. The sustained
calcium response could be the result of store-operated
channels in which a calcium-induced calcium release
produces a wave that passes from one cell to the next
through gap junctions (Sanderson et al., 1990). Transfec-
tion of COS-1 cells with a Golgi-specific Ca2+ pump
reveals oscillations also resulting from calcium release
from non-ER calcium store(s) (Missiaen et al., 2001). It
has been shown in primary rat mammatropes that the
oscillation pattern of a single cell could change from one
distinct pattern to another over time (Shorte et al., 2000;
Villalobos et al., 1998). Clearly, additional studies are
required to define the mechanism(s) of calcium oscillation
patterns observed with the SIV SU peptides.
SIVmac, SIVpbj, and SIVcon assumed a mostly ran-
domly coiled structure in aqueous buffer (14–17% a
helix) that significantly increased in a-helical content
(28–32%) when exposed to a hydrophobic environment
(TFE), an environment known to favor secondary struc-
ture in peptides by promoting intramolecular hydrogen
bonding. NSP4114–135 shows the same trend with 37% a-
helical structure in buffer that increases to 91% in the
presence of TFE (Huang et al., 2001). In addition, the
SIV and NSP4 enterotoxic peptides preferentially inter-
acted with defined membrane lipid domains with a high
radius of curvature and rich in anionic phospholipids
(Huang et al., 2001). The radius of curvature increases
as the diameter of the lipid vesicle decreases, such that
SUV with an average diameter of 25 nm has a high
radius of curvature with an outer to inner membrane lipid
mole ratio of 2.2:1 (Cullis et al., 1996). In contrast, the
mean diameter of the LUV is larger, the radius of
curvature decreases, and the distribution of lipid between
the outer and inner membranes is close to 1:1. Hence, the
increased helical content of the SIV peptides with vesicles
of a high radius of curvature may be due to the increased
exposure of anionic lipids on the outer leaflet.
The NSP4 peptide preferentially bound cholesterol-rich
vesicles, while SIV peptide–membrane interaction(s)
appeared to require cholesterol, but additional molar
concentrations above 35% failed to enhance membrane
interactions. The intestinal microvillus is enriched in the
number of membranes that are highly curved (Boffelli et
al., 1997; Lipka et al., 1995), which may enhance
infection and activity of the virus and the enterotoxic
protein. Additionally, cholesterol-rich rafts have been
shown to stabilize HIV-1 and SIV integrity and infectivity
(Graham et al., 2003). Consequently, the SIV SU peptides
may interact with lipid rafts on the cell surface. This
correlates with a study by Nehete et al. (2002), which
shows HIV V3 loop peptides specifically bind host cellglycosphingolipids that may be a critical post-CD4-bind-
ing event.
We have identified an enterotoxic domain within SIV
SU of two diverse strains, SIVsmmPBj14 and SIV-
mac239, which corresponds to the putative HIV-1 SU
enteropathic domain overlapping the V3 loop. These data
suggest that full-length SU is not essential for activity and
that these two strains of SIV contain an enteropathic
region, as seen with HIV-1. In this study, the mouse
provided a convenient, small animal model to readily
evaluate the presence of and differences in enterotoxic
activity of the SIV peptides. Additional studies examining
the SU glycoprotein or synthetic peptides of other lenti-
viruses are needed to determine if the enterotoxic nature
of SU is a common lentivirus virulence factor. Finally,
these data, together with additional studies of the enter-
otoxic properties of HIV or SIV, may direct future studies
in the development of therapeutics against HIV- or SIV-
induced GI dysfunction.Materials and methods
Selection of peptides
Synthetic peptide sequences were selected from algo-
rithms that predict surface potential (Parker et al., 1986),
turn potential, and amphipathic structure (Margolit et al.,
1987). We selected peptide sequences calculated to be
amphipathic, hydrophilic, and overlapped the V3 region
as the putative enteropathic peptides. Peptide selection was
limited to the V3 loop region of SIV SU because it has
been shown that HIV-1 V3 alters calcium homeostasis and
could be enteropathic (Dayanithi et al., 1995). The control
peptide was selected because of its predicted amphipathic
structure, similar charge to the V3 peptides, centrally
located tyrosine (Y) residue, and the SU C-terminal
location (from the same protein). Note that charge, amphi-
pathic character, and a centrally located Y were shown to
be critical to the NSP4 peptide enterotoxic activity (Ball et
al., 1996). Likewise, the control Nowalk virus peptide used
in the NSP4 study was amphipathic, highly charged, and
contained a central Y residue, yet was not active in any of
the assays. Likewise, several of our assays were tested
with the Norwalk virus control peptide to ensure the assays
were functioning similar to what was seen in the original
NSP4 study (data not shown).
Peptide synthesis, purification, and characterization
SIVmac239 (352 – 382) (DAIKEVKQTIVKH-
PRYTGTNNTDKINLTAPG) (GenBank ID# 135474),
SIVsmmPBj41 (360 – 390) (KAIQEVKETLVKH-
PRYTGTNKTEQIKLTAPG) (Dewhurst et al., 1992), and
SIVmac239 (496–525) (non-V3 loop control) (DYKL-
VEITPIGLAPTDVKRYTTGGTSRNKR) were synthesized
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pore Corporation, Marlborough, MA) using 9-fluorenylme-
thylcarbonyl (Fmoc) chemistry following standard
activation and deprotection protocols. The peptides are
called SIVmac, SIVpbj, and SIVcon, respectively. All
chemicals for peptide syntheses were obtained from Per-
Septive Biosystems (Framingham, MA). Following cleav-
age of the peptide from the solid support, 90%
trifluoroacetic acid (TFA), 5% thioanisole, 3% ethanedi-
thiol, 2% anisole, and the peptide–resin mixture were
filtered through a Buchner funnel (20C fritted disc) into
a polypropylene tube containing ice-cold anhydrous ethyl
ether. The precipitated peptides were pelleted (225  g)
for 3–5 min, extracted with ether and pelleted three more
times, dried under compressed nitrogen gas, solubilized in
10% glacial acetic acid, and lyophilized (Dura Dry MP
Microprocessor Controlled Freeze Dryer, FTS Systems,
Inc., Stone Ridge, NY). The crude peptides were purified
by gravimetric gel filtration chromatography (Sephadex G-
25M, Sigma) monitored at 220 nm (ISCO model 229 UV–
VIS detector, ISCO, Lincoln, NE) and analyzed by re-
verse-phase HPLC (Beckman System Gold, Fullerton, CA)
on a C4 analytical column (Waters C4 Delta Pak column,
Milford, MA). Purified peptides were evaluated by
MALDI/Time of flight mass spectroscopy (Laboratory for
Biological Mass Spectroscopy, Department of Chemistry,
Texas A&M University). Peptide fractions with the correct
theoretical mass were used in this study (SIVmac = 3424,
SIVpbj = 3478, SIVcon = 3350).
Endotoxin assay
Purified peptides and phosphate-buffered saline (PBS)
were assayed for the presence of endotoxin using the
Limulus Amebocyte Lysate (LAL) test (Associates of
Cape Cod, Inc., Falmouth, MA) in endotoxin-free flint
(soda lime) glass tubes according to the manufacturer’s
protocol. A value of 0.5 EU/ml or less was considered
acceptable for use in our experiments.
Mouse inoculation and diarrhea scoring
Balb/C mice were acquired from Harlan Sprague–
Dawley, Inc. (Indianapolis, IN) or Charles River Labora-
tories (Wilmington, MA) and housed at Texas A&M
University Laboratory Animal Resources and Research
Facility. Purified SIVpbj, SIVmac, and SIVcon peptides
were diluted in 50 Al sterile, endotoxin-free PBS and
were injected intraperitoneally (IP) into 6–8-day-old pups
using a 30-G needle. To determine if the diarrheal
response was dose-dependent, 0.0005–10 mM of SIVpbj
and SIVmac were administered to 86 and 57 pups,
respectively. Pups were administered 2 mM SIVcon
(n = 29) or PBS (n = 17), which served as the negative
controls. Following injection, the pups were monitored for
diarrhea as previously described and scored by one personon a scale of 1 to 4 (Ball et al., 1996; Swaggerty et al.,
2000).
Histological analysis
Peptides were surgically introduced into mouse intestinal
loops as previously described (Swaggerty et al., 2000).
Eleven animals were administered 50 Al SIVmac (2 mM)
dissolved in sterile, endotoxin-free PBS while six animals
were given the same concentration and volume of SIVpbj.
Twenty-one animals received 50 Al SIVcon (2 mM) or PBS
and served as the negative controls. SIV peptide-treated
loops were examined for histological changes as previously
described (Swaggerty et al., 2000). The intestinal loops were
fixed in neutral buffered formalin for 24 h. An unmanipu-
lated segment of intestine not included in the intestinal loop
from each animal was removed to serve as a control.
Representative sections of the loop were processed, embed-
ded, sectioned, and stained with instant hematoxylin (Shan-
don, Pittsburgh, PA) and eosin (Sigma) as per routine
methodology for microscopic examination.
Loading HT-29 cells with Fluo-4 for calcium imaging
HT-29 cells, human colon adenocarcinoma (ATCC,
Rockville, MD), were seeded at 1.0  104 cell/ml into
LAB-TEK 4-well chamber slides with coverglass slides
(0.75 ml/well) (Nalge Nunc International Corporation,
Naperville, IL) and allowed to grow for 12–16 h at 37
jC, 5% CO2. Cells were loaded with Fluo-4 (Molecular
Probes, Eugene, OR) in 500 Al physiological calcium-free
buffer (PCFB [150 mM NaCl, 5 mM KCl, 10 mM glucose,
20 mM HEPES, 1 mM MgCl]) (Steinberg et al., 1987)
containing 3% FBS and 0.04% Pluronic F-127 (Sigma) as
previously described (Swaggerty et al., 2000). SIVmac,
SIVpbj, SIVcon (300 AM final concentration), or neuro-
tensin (0.005 AM final concentration) was diluted in 200
Al PCFB and added to the cells immediately before analysis
and data collection.
Laser scanning confocal microscopy (LSCM)
The calcium imaging studies were performed on a MRC-
1024 laser scanning confocal microscopy (LSCM) imaging
system controlled by LaserSharp software (Bio-Rad, Labo-
ratories, Hercules, CA). A region of 10–20 cells was
randomly selected, the median section along the z-axis of
the cells was viewed, and the calcium kinetics monitored by
acquiring images at 10-s intervals and calculating the
average pixel intensity using the Time Course Software
(Bio-Rad Laboratories).
LSCM was also utilized to determine if the peptides
penetrated the cell membrane or if they were bound and
localized to the outside of the cell. HT-29 cells were grown
to 80% confluency in LAB-TEK 4-well chambered cover-
glass slides, treated with 300 AM SIVmac or SIVcon for 10
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performed. The peptides were removed and the cells rinsed
with PBS and fixed and permeabilized with ice-cold meth-
anol/acetone (1:1) for 10 min at 20 jC. The slides were
dried, rehydrated with PBS, and then incubated in blocking
buffer (3% dry milk in PBS with 0.02% Triton X-100) for 1
h at 25 jC. Primary antibodies (rabbit-anti-SIVcon, mouse-
anti-SIVmac, normal rabbit, or normal mouse sera) prepared
in 1% dry milk in PBS were added to the cells and incubated
for 1 h at 25 jC. Following four washes with 0.5% dry milk
in PBS, secondary antibodies (anti-rabbit IgG, H and L
chain (goat)-FITC [Calbiochem-Novabiochem Corporation,
San Diego, CA] or anti-mouse IgG (goat)-FITC [Jackson
Immuno Research Laboratories, West Grove, PA]) prepared
in 1% dry milk were added to the cells and incubated for 30
min at 25 jC, washed, then viewed (488 line, 3–10% laser
power, 522/DF35 filter).
Specificity of the calcium response
SIVmac, SIVpbj, and SIVcon peptides (2 mM) were
prepared in PCFB. The peptides were incubated for 1 h at 25
jC with 1:10 or 1:100 dilutions of corresponding antibodies.
Because SIVmac and SIVpbj shared highly homologous
sequences (74% identity), they were both blocked with
mouse-anti-SIVmac antiserum; SIVcon was blocked with
rabbit-anti-SIVcon antiserum. Both antisera were mixed
with 10 nM neurotensin at a 1:10 dilution to control for
nonspecific inactivation. After the HT-29 cells were loaded
with Fluo-4, 200 Al of antisera-treated SIVmac, SIVpbj,
SIVcon (1 mM final concentration) or neurotensin (0.005
AM final concentration) was diluted in 200 Al PCFB, added
to the cells, and evaluated for calcium kinetics.
Inositol 1,4,5-triphosphte (IP3) measurements
To determine if the mechanism of peptide-induced
[Ca2+]i mobilization is similar to full-length SU, the IP3
assay was performed as previously described (Swaggerty et
al., 2000). HT-29 cells were either mock-treated or treated
with 300 AM SIVmac, SIVpbj, SIVcon, or 0.01 AM neuro-
tensin prepared in Na-HEPES-buffered saline (140 mM
NaCl, 4.7 mM KCl, 1.13 mM MgCl2, 10 mM HEPES, 10
mM glucose, 1 mM CaCl2) for 45 s. Samples were assayed
for IP3 by a competitive radioreceptor assay (Amersham
Pharmacia Biotech [kit number TRK1000], Piscataway, NJ)
according to the manufacturer’s instructions. Radioactivity
in 5 ml scintillation fluid (CytoScint (ICN Biomedicals, Inc.
Irvine, CA) was measured for 4 min using a 1600 TR Tri-
Carb liquid scintillation analyzer (Packard Instrument Com-
pany, Downers Grove, IL).
Preparation of small unilamellar vesicles (SUV)
The interactions of the enterotoxic peptides with specific
lipid domains were examined using small and large uni-lamellar vesicles (SUV and LUV, respectively) composed
of the phospholipids 1-Palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC or PC) and 1,2-dioleoyl-sn-glyc-
ero-3-[phospho-L-serine] (DOPS or PS) and cholesterol
(Avanti Polar Lipids, Alabaster, AL). SUVs composed of
varying molar ratios of PC/cholesterol/PS (molar ratio
65:35:0, 55:35:10, 35:35:30, 40:50:10) were prepared by
sonication and analyzed as previously described (Hapala et
al., 1994; Schroeder et al., 1987). Solvents were removed
under N2 with constant rotation and were subsequently
dried under vacuum for a minimum of 4 h. The sample was
diluted in prefiltered 3-[N-morpholino] propane-sulfonic
acid buffer (MOPS, 10 mM), pH 7.4, vortexed, bath
sonicated, and vortexed again. The resultant multilamellar
membrane suspension was sonicated with a microprobe
(Sonic Dismembrator Model 550, Fisher) under N2 at 4 jC
at energy level 4 using 1-min pauses after every 2 min of
sonication to prevent overheating. The sonicated solution
was centrifuged using a 40 Ti rotor (Beckman) at 35 K for
4 h to remove any multilamellar vesicles and titanium
debris left from the sonicator probe. This protocol was
shown to produce vesicles with a diameter of 20–30 nm by
photon correlation spectroscopy and with a high radius of
curvature (Huang et al., 1999, 2001). The lipid concentra-
tion of the final SUV solution was determined by a
standard phosphate assay (Ames, 1968). UV absorbance
was recorded at 660 nm and the concentration of the
phospholipids in the SUV was calculated using a standard
curve of the UV absorbance plotted against a known
concentration of phospholipid.
Preparation of large unilamellar vesicles (LUV)
For comparison, large unilamellar vesicles (LUV) were
prepared by extrusion through polycarbonate membranes.
All procedures were the same as described for the prepara-
tion of the SUV, except sonication was omitted. Instead, the
lipid suspension was freeze–thawed five times and extruded
21 times (back and forth) through double layers of 0.1 Am
polycarbonate membranes in a mini-extruder (Avanti Polar
Lipids) which produces vesicles with a diameter of 100–
120 nm by photon correlation spectroscopy (Huang et al.,
1999, 2001) and a small radius of curvature.
Secondary structure estimation by circular dichroism (CD)
Secondary structures of the peptides were determined in
aqueous buffer and trifluoroethanol (TFE), a hydrophobic
solvent. To determine if the SIV SU peptides interact with
caveolae-like membranes, similar to the NSP4 enterotoxic
peptide, interactions of the three SIV peptides with SUV
and LUV were determined by circular dichroism (CD)
following a modified procedure (Huang et al., 2001;
Stolowich et al., 1997). The concentration of the peptide
solution was determined by amino acid analysis (Protein
Chemistry Core Laboratory, Texas A&M University). The
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mM lipid vesicles, buffer alone (10 mM phosphate buffer,
pH 7.4), or lipid vesicles without peptide was examined by
CD. CD spectra were obtained at 25 jC in a 1 mm circular
quartz cell and a Model J-710 Spectropolarimeter (JASCO
Inc, Easton, MD). Each CD spectrum was from 185 to 260
nm with a step resolution of 1 nm, speed of 50 nm/min,
response of 1 s, bandwidth of 2.0 nm, and sensitivity of 10
mdeg. Data from 10 scans were averaged, background
subtracted, and converted to mean residue molar ellipticity
[h] (deg cm2/dmol).
The equation h222 = (h  ij / N)[hh 222l] was used to
estimate the percent helix for each peptide with h222 as the
mean residue molar ellipticity at 222 nm, h as the fraction
in a-helical form, i as the number of helices, j as a
wavelength-specific constant with a value of 2.6 at 222
nm, N as the number of residues in the peptide, and hh 222l
represents the molar ellipticity for a helix of infinite length
at 222 nm (i.e., 39500 deg cm2/dmol) (Chang et al.,
1978; Chen et al., 1974).Acknowledgments
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